Skip to main content
Download PDF

Epidemiology of TB in prisoners: a metanalysis of the prevalence of active and latent TB

BMC Infectious Diseases volume 23, Article number: 20 (2023) Cite this article

Abstract

Background

Tuberculosis (TB) in prisons usually occurs at higher rates than in the general population, especially in developing countries. TB has been reported as the most common cause of death among prisoners. Studies have shown limitations for early detection of TB in prisons that seem to result from mistaken concepts about TB, delayed diagnosis mainly due to the naturalization of lack of healthcare for this population

Methods

A scoping review was performed using the methodology of the Joanna Briggs Institute to assess “What are the scientific evidences on the epidemiology of TB in the prison system?”. Then, a meta-analysis was performed to assess the prevalence of TB (active and latent) TB in prisoners. The results are presented as prevalence, in percentage, through random effects models, with a confidence interval of 95%.

Results

Regarding active TB, the results of the metanalysis showed that countries with a high burden of TB had a prevalence of 3.54% [2.71; 4.63], countries not considered to be high burden TB countries had a prevalence of 1.43% [0.86; 2.37]. Latent TB had a prevalence of 51.61% [39.46; 63.58] in high TB burden countries and a prevalence of 40.24% [23.51; 59.61] in countries with low TB burden. In terms of development, in low- and lower-middle-income countries, the prevalence of active TB was 3.13% [1.84; 5.29] and in high- and upper-middle income countries the prevalence was 2.25% [1.70; 2.99]. The prevalence of latent TB in high- and middle-income countries was 43.77% [28.61; 60.18] and of 49.42% [45.91; 52.94] in low and lower middle-income countries.

Conclusion

Our analysis suggests that TB, and probably other infectious diseases, find fertile ground in prisons where previous acquire social disadvantages seem to thrive—therefore, TB in prisons is a global public health problem and effective strategies are needed to control the disease are needed targeting the prison environment, including rapid health assessments to understand each context and to implement tailored and precision interventions.

Peer Review reports

Background

Tuberculosis (TB) is a communicable disease and one of the ten leading causes of death worldwide. It is also the leading cause of death by a single infectious agent, surpassing HIV [1].

TB in prisons usually occurs at higher rates than in the general population, especially in developing countries. TB has been reported as the most common cause of death among prisoners [2]. A disproportionated number of prisoners belong to population groups that already present a high risk of infection and TB disease (e.g., substance users, homeless individuals, individuals with mental illness, ex-convicts, HIV/AIDS and immigrants) and have often higher prevalence of TB [3, 4].

During incarceration, prisoners face living conditions, such as crowding, absent or precarious basic sanitation and housing infrastructure, malnutrition, poor ventilation, deficient lighting, illicit drug use and difficulty in accessing health services, that make the prison system a potential TB-transmitting (and aggravating) environment [2,3,4,5].

Studies have shown limitations for early detection of TB in prisons that seem to result from mistaken concepts about TB, delayed diagnosis mainly due to the naturalization of lack of healthcare for this population, interpretation of prisons as places of "death" and "suffering" and, in some situations, deprivation of the right to health for detainees due to their position before society [6, 7]. These factors translate into inequities in accessing health services, including TB related prevention, diagnosis, and/or treatment services. Studies also point out the misconceptions of the right to health of prisoners and consequently, the need to change the understanding of this basic human right [8].

TB in prisoners is, thus, a major public health concern that contributes to the dissemination of TB and the perpetuation of its effects not only in this population but in society in general.

Several types of reviews have addressed the issue of TB in prisoners (12 review studies, 6 systematic reviews, 2 metanalysis, 2 integrative reviews, 1 comprehensive review and 1 scoping review) [8,9,10,11,12,13,14,15,16,17,18,19]. Nevertheless, none comprehensively addressed scientific evidence of the epidemiology of TB in the prison system worldwide.

We conducted a scoping review (SR) to address the review question “What are the scientific evidences on the epidemiology of TB in the prison system?”. For the purposes of this SR, we defined epidemiology as events, states, health processes and factors involving TB in prisoners described as incidence, prevalence, associations, comparisons, predictions, correlations, descriptions, risks, trends or probabilities resulting from studies.

The large number of prevalence results found led us to carry out the meta-analysis reported in this paper.

Methods

A SR was performed using the methodology of the Joanna Briggs Institute [20].The protocol for this scoping review is registered in the Open Science Framework under https://osf.io/vn2cw/.

Search strategy

Databases were searched in June 2021. No time limit was applied. We searched Medical Literature Analysis and Retrieval System Online (MEDLINE/PubMed); Latin American and Caribbean Literature in Health Sciences (LILACS); Scopus (Elsevier) and Scientific Electronic Library Online (SciELO) using the following search terms and keywords: Tuberculosis, Kochs Disease, Koch's Disease, Koch Disease, Mycobacterium tuberculosis Infection, Mycobacterium tuberculosis Infections, Prisons, Prison, Penitentiaries, Penitentiary, Prisoners, Prisoner, Prison inmate. The search strategies used in each database are detailed in Additional file 1.

Eligibility criteria

Inclusion criteria

We adopted the strategy: Population (P), Concept (C), Context (C) [21] as defined in Table 1.

Table 1 Data search strategy
Full size table

Studies that presented cases of TB in all clinical forms (i.e., all forms of active TB and latent TB, considered the inactive form of the disease) from A-15 to A-19 according to the International Classification of Diseases version 10—ICD-10 were included [22].

Exclusion criteria

We excluded publications that investigated other infectious diseases and that had no data on TB, that addressed the relationship between TB and drug use, studied immigrant population who were also deprived of liberty, TB coinfection with HIV and/or Hepatitis C; molecular epidemiology of TB, TB lineage variation; TB after leaving the prison system; drug resistant TB; sensitivity testing methods; performance of scores for TB screening; case studies; cost of TB tests in prisons; prisoners of war with TB; summaries of official TB control consensus documents in the prison system; and qualitative studies.

Selection process

References retrieved from databases were assessed independently (title and abstract) by two reviewers (AP and DS), after removal of duplicates. Disagreements were resolved by a third reviewer (IF). Publications eligible for full-text reading were again assessed independently by two reviewers (AP and DS).

Data extraction and analysis

Data extraction was conducted by AP and DS using an adapted version of the form of the JBI [20] model according to the specificities of this SR that included: type of study, language, aims, population, concept, context, source of evidence, citation details, country, methods and relevant results.

Included studies were divided into the following categories: prevalence, incidence, associated factors, treatment outcomes, environmental factors and effects of prevention programs. In this paper, we report only on included studies that presented prevalence data. All studies addressing prevalence of TB were assessed in terms of quality and risk of bias and subjected to meta-analysis.

Assessment of quality and risk of bias

We used the JBI critical appraisal tools for prevalence studies and for cross-sectional studies [23]. Critical appraisal was conducted by DS, AS, MS and HM. AP was consulted whenever there were questions or doubts. The Checklist for Analytical Cross-Sectional Studies was used when the studies did not have as main objective to evaluate the prevalence of TB, but presented TB prevalence data. The Checklist for Prevalence Studies was used when the aim of the study was to evaluate the prevalence of TB.

Each checklist consists of eight (cross-sectional) or nine questions (prevalence), with four options of answer: yes; no; unclear and not applicable. To decide on the quality of the studies and to define which were low, medium or high quality we attributed a score to each item, being, 2 for yes or not applicable, 1 for unclear and 0 for no. The score obtained in each question was then added to reach a final score. For the critical appraisal tool for cross-sectional studies, low quality refers to studies scoring 0 to 8, medium quality to studies scoring 9 to 12 and high quality to studies scoring higher than 12. For the critical appraisal tool for prevalence studies, low quality corresponded to a 0 to 9 score, medium quality to a 10 to 14 score and high quality to a score of 15 or higher.

This study had the publication bias of not analyzing the gray literature, in addition to not including studies that were not published because they did not present data considered relevant for publication.

Meta-analysis

Meta-analysis was performed to assess the prevalence of TB (active and/or latent) in prisoners. The results are presented as prevalence, in percentage, through random effects models, with a confidence interval of 95%. The heterogeneity between the studies was evaluated using the I2 test, in which values ​​above 50% and p-value less than 0.05 were considered as high heterogeneity [24].

To be included in the meta-analysis, the study had to inform on the number of people with TB, active and/or latent, and the total sample size. If the study only provided data on the percentual prevalence, the number of people was calculated. Analysis was stratified according to the burden of TB in the country where the study was conducted (high burden country for TB/ not high burden country for TB). We used the list of countries of high TB burden of the Global Tuberculosis Report of 2020 [25]. Analysis was also stratified by income level as defined by the World Bank (high- or upper-middle-income/ low- or lower-middle-income country) [26]. To analyze the trend in TB prevalence, we used the years of data collection for each study. Analysis was performed using the R programming language, using the Meta package [27].

Results

Characteristics of the studies

Searches of the databases yield a total of 3122 articles (1300 from PubMed, 1643 from Scopus, 94 from LILACS and 85 from SciELO) of which 1148 were duplicates and 283 were in other languages besides those defined for this SR. A further 1493 articles were excluded after applying eligibility criteria to title and abstract. A total of 268 publications were considered for full-text assessment, of which 30 were excluded because it was not possible to access them, 55 did not meet the eligibility criteria (16 were qualitative studies, 8 addressed Multi-drug resistant TB (MDR-TB), 5 studied prisoners with co-infection TB-HIV, 3 compared strains of Koch bacilli, 3 concerned TB outbreaks, 2 studied homeless people, 2 were on-going clinical trials, 2 jointly addressed prison officials and prisoners, 3 were editorials, 3 were commentaries, 3 were on vulnerable populations as a whole, 2 were legislative reviews, 3 specific evaluations and tests on incarceration rate, increased risk of TB in the general population or juvenile prisoners) and 3 were duplicates not previously identified. A total of 180 articles met the inclusion for the initial scoping review and of these 74 studies presented prevalence results and were included in the meta-analysis reported in this paper (see Fig. 1).

Fig. 1
figure 1

PRISMA flow diagram illustrating the search process which eligible articles was identified for data synthesis

Full size image

Of the 74 studies with prevalence results, 59 included data on the prevalence of active TB and 15 on the prevalence of latent TB in prisons and were analysed separately. The country with the highest number of manuscripts was Brazil (n = 19), followed by Ethiopia (n = 9), USA (n = 5), Spain (n = 3) and Zambia (n = 3), Malaysia (n = 2), Malawi (n = 2), Pakistan (n = 2), Bangladesh (n = 2), South Africa (n = 2) and India (n = 2), Turkey (n = 2), Colombia (= 2) (Table 2). Several countries had only one study each. Publications dates ranged from 1986 to 2021. The number of participants ranged from 164 to 622,000 prisoners.

Table 2 Results of quality appraisal
Full size table

Quality of evidence

Only three of 74 studies assessed had low quality [27,28,29], 13 had medium quality [30,31,32,33,34,35,36,37,38,39,40,41,42] and 58 were considered high quality [43,44,45,46,47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69,70,71,72,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87,88,89,90,91,92,93,94,95,96,97,98,99,100].

The low quality studies evaluated the prevalence of TB in populations or samples of prisoners without TB symptoms [27, 28] and one study evaluated the prevalence only in symptomatic prisoners [29]. Three of the medium quality studies evaluated the prevalence of latent TB [40,41,42], nine TB in non-symptomatic patients [30,31,32,33,34,35,36,37,38] and one the prevalence of TB in symptomatic patients [39]. Results of quality appraisal are presented in Table 2.

Meta-analysis

Regarding active TB, the results of the metanalysis showed that countries with a high burden of TB had a prevalence of 3.54% [2.71; 4.63] with a total population in all studies of 800,121 prisoners. Countries not considered to be high burden TB countries had a prevalence of 1.43% [0.86; 2.37] with a total population in all studies of 212,127 prisoners. Still in relation to active TB, when analysing all countries together, the overall prevalence of active TB was 2.62% [2.06; 3.33] adding up to a total population of 1,012,448 prisoners (see Fig. 2).

Fig. 2
figure 2

Prevalence of general tuberculosis by burden of TB of the country

Full size image

Latent TB had a prevalence of 51.61% [39.46; 63.58] with a population of 6,833 prisoners in high TB burden countries and a prevalence of 40.24% [23.51; 59.61] and a population of 53,975 prisoners in countries with low TB burden. The overall prevalence of latent TB was 44.37% [30.00; 59.75] with a total population of 60,808 prisoners (see Fig. 3).

Fig. 3
figure 3

Prevalence of latent tuberculosis by burden of TB of the country

Full size image

Prisoners with suggestive TB symptoms had a prevalence of TB of 7.37% [5.41;9.97] in high burden countries with a total population of 4737 prisoners, and a prevalence of 3.30% [0.84;12.10] in a population of 1476 in low burden countries. Overall, the prevalence of TB in symptomatic prisoners was 5.89% [4.08;8.42] in a population of 6,213 prisoners (see Fig. 4).

Fig. 4
figure 4

Prevalence of symptomatic tuberculosis by burden of TB of the country

Full size image

In terms of development, in low- and lower-middle-income countries, the prevalence of active TB was 3.13% [1.84; 5.29] for a total population of 147,706 prisoners. In high- and upper-middle income countries the prevalence was 2.25% [1.70; 2.99] with a population of 864,542 prisoners. Adding up all countries, the prevalence was 2.62% [2.06; 3.33] with a total of 1,012,248 prisoners (see Fig. 5).

Fig. 5
figure 5

Prevalence of general tuberculosis by income level of the country

Full size image

The prevalence of latent TB in high- and middle-income countries was 43.77% [28.61; 60.18] in a population of 60,031 prisoners and of 49.42% [45.91; 52.94] in low and lower middle-income countries with a population of 777 prisoners. The total prevalence of latent TB was 44.37% [30.00; 59.75%] in a total of 60,808 prisoners (see Fig. 6).

Fig. 6
figure 6

Prevalence of latent tuberculosis level of the country

Full size image

Symptomatic TB had a prevalence of 6.33% [4.50;8.82] in low- and lower-middle-income countries with a total population of 3536 prisoners, and a prevalence of 5.94% [2.33; 14.33] in a population of 2677 in high- and upper-middle-income countries. Overall, the prevalence of TB in symptomatic patients was 5.89% [4.08;8.42] in a population of 6,213 prisoners (see Fig. 7).

Fig. 7
figure 7

Prevalence of symptomatic tuberculosis by income level of the country

Full size image

Active TB had a prevalence of 3.09% [2.39;3.99] in a population of 838,374 prisoners in high-quality studies. In studies with average quality, the prevalence of TB was 1.45% [0.65; 3.19] in a population of 135,223 prisoners, and in low quality studies the prevalence of TB was 1.43% [0.49; 4.08] in a population of 38,651 prisoners (see Fig. 8).

Fig. 8
figure 8

Prevalence of general tuberculosis according to the quality of the studies

Full size image

Latent TB had a prevalence of 45.75% [28.94; 63.59] in a population of 54,903 prisoners in high-quality studies. In studies with average quality, the prevalence was 39.29% [15.48; 69.56] in a population of 5,905 prisoners (see Fig. 9).

Fig. 9
figure 9

Prevalence of latent tuberculosis according to the quality of the studies

Full size image

TB in symptomatic patients had a prevalence of 4.87% [3.08; 7.62] in a population of 4486 prisoners in high-quality studies. In studies with average quality, the prevalence was 9.20% [7.77; 10.86] in a population of 1,348 prisoners. In low quality studies the prevalence of TB in symptomatic patients of 13.98% [10.84; 17.85] in a population of 379 prisoners (see Fig. 10).

Fig. 10
figure 10

Prevalence of Symptomatic tuberculosis according to the quality of the studies

Full size image

In the analysis of the trend of TB prevalence in the studies, we found a TB prevalence of 0.89% [0.16; 4.73] for studies from the 80 s and 90 s. Studies between the years 2000 and 2004 had a prevalence of 4.09% [1.58; 10.18], between 2005 and 2009 the prevalence was 1.58% [0.79; 3.16], between 2010 and 2014 the prevalence was 3.74% [2.49; 5.59] and the studies between 2015 and 2019 resulted in a prevalence of 3.21% [2.05; 5.01]. The total prevalence of TB in the studies was 2.59% [1.86; 3.58] (see Fig. 11).

Fig. 11
figure 11

Trend in the prevalence of tuberculosis in prisoners

Full size image

Trend analysis of latent TB prevalence was 33.75% [16.35; 57.04] in studies from the 1980s and 1990s, a prevalence of 45.89% [29.49; 63.24] between 2000 and 2004, the prevalence between 2005 and 2009 was 56.72% [35.36; 75.84], we found a prevalence of 43.71% [16.76; 74.96] between 2010 and 2014 and a prevalence of 53.50% [50.34; 56.63] between 2015 and 2019. The total prevalence of latent TB in the studies was 44.34% [32.74; 56.59] (see Fig. 12).

Fig. 12
figure 12

Trend in the prevalence of latent tuberculosis in prisoners

Full size image

The trend analysis of the prevalence of TB in symptomatic patients was 6.42% [3.64; 11.08] between the years 2005 and 2009, between 2010 and 2014 the prevalence was 5.36% [2.62; 10.66]. Between the years 2000 and 2004 and between 2015 and 2019 we found only one study in each period with a prevalence of 11.11% [5.68; 19.01] and 2.92% [1.47; 5.16]. The overall prevalence of TB in symptomatic patients was 5.72% [3.57%; 9.05] (see Fig. 13).

Fig. 13
figure 13

Trends in the prevalence of tuberculosis in symptomatic prisoners

Full size image

Discussion

This paper reports the results on a metanalysis of the prevalence of TB, latent TB in prisoners and TB in prisoners presenting suggestive symptoms of TB reported by studies included on a broader scoping review addressing the epidemiology of TB in this population.

A total of 74 papers reported data on prevalence of TB. The combined analysis of data revealed that the prevalence of active TB was 2.5 times higher in high TB burden countries when compared to low burden countries [1]. The latent TB prevalence was also higher (1.2 times) in high TB burden countries. The same trend was seen in studies assessing the prevalence of TB in prisoners with suggestive symptoms of TB, where the prevalence of the disease was 2.3 times higher in countries with high TB burden.

These findings were not a novelty since it would be expected for prisoners in countries with high burden of TB to also have higher prevalence of TB (active or latent). Prisons produce favourable conditions for the expansion of the TB epidemic in the general population. A study carried out in Brazil showed that incarcerated individuals enter prisons with a low risk of TB [101]. However, this risk increases rapidly over 5 years, reaching a peak of more than 1300 cases per 100,000 person-years, being 30 times greater than that of the general population. When prisoners are released and return to the community, they present a 5.5 times greater risk of active TB than the general population. The risk remains elevated for 7 years [101].

When comparing studies conducted in low- and low-middle-income countries with those in high and high-middle income, it was also possible to observe higher prevalence in low- and low-middle-income countries of active and latent TB and among symptomatic prisoners [25]. However, there were only two studies on latent TB in low- and middle-low-income countries, with a small number of participants, reason why results should be carefully interpreted.

In this analysis, only 22 studies were conducted in high burden TB countries who were middle/high income countries (Brazil, Thailand and South Africa), with 19 of them being conducted in Brazil. The remaining studies were done in low- and lower-middle-income countries with high burden of disease. More than 90% of reported TB infections occur in low- and middle-income countries [102]. Low-income contexts tend to be more prone to racial issues inside and outside prisons. Brown and black populations suffer more individual and social deprivation in different parts of the world, making their surroundings deficient, exhausting and a potential disease generator. Inside prisons, this situation is no different, studies show that in this environment presents greater notification of TB in brown and black groups and with low education [103,104,105]. In addition, the prison population in general also belongs to this social group, as in Brazil, 67% of its prison population is black or mixed-race and 61% are illiterate or with low education [106, 107].

High quality studies had active TB prevalence rates circa 2.1 times higher than medium and low-quality studies. In relation to latent tuberculosis, high-quality studies had higher rates than those of medium quality. In studies that included symptoms of TB, the rates were higher in the two medium and low quality ones, thus resulting in a frail evidence of this difference.

The global prevalence of latent TB in the general population according to the World Health Organization-WHO is a quarter of the world's population [108]. A systematic review with meta-analysis was performed in 2019 revealed a prevalence of 24.8% (95% CI 19.7–30.0%) of latent TB in the general population worldwide [109]. These data show a discrepancy in relation to the data found in our study with the prisoner population.

In the general population, in 2018, about 10 million people were notified with TB worldwide, equivalent to 132 per 100,000 population a 2% decline from 2017. From 2000 to 2018 there was a 1.6% drop in the incidence of TB in the general population [110]. According to the WHO, over a 20-year period, the overall incidence of TB ranged from a maximum of 174 cases per 100,000 population in the year 2000 to a minimum of 127 cases per 100,000 population in the year 2020, these numbers are lower than those found in the prisoner population [111].

Focusing interventions on prisons can have powerful effects in reducing TB rates in the general population as investing in tuberculosis control in 0.5% of the population would reduce the total incidence of active TB in the population by more than 40% [101].

Conclusion

Prisons are potentially transmitting place for TB: not only due to its poor structure conditions but also because of the social issues that migrate from the outside world with the imprisonment of individuals.

The metanalysis conducted suggests that TB, and probably other infectious diseases, find fertile ground in prisons where previous acquired social disadvantages seem to thrive.

Therefore, TB in prisons should be understood as a global public health problem because TB is not only a health problem, but also a social problem, effective strategies to control the disease are needed targeting the prison environment, including rapid health assessments to understand each context and to implement tailored and precision interventions.

Availability of data and materials

All data generated or analyzed during this study are included in this publication. The references of the analyzed articles are available in Table 2 of this manuscript. Additional file 1 includes the sequence of words and databases used for the search.

Abbreviations

TB:

Tuberculosis

HIV:

Human Immunodeficiency Virus

AIDS:

Acquired Immunodeficiency Syndrome

SR:

Scoping review

MDR-TB:

Multidrug-resistant tuberculosis

WHO:

World Health Organization

References

  1. World Health Organization. Global tuberculosis report 2020. Geneva: World Health Organization; 2020.

    Google Scholar 

  2. Reyes H, Coninx R. Pitfalls of tuberculosis programmes in prisons. BMJ. 1997;315:1447–50.

    Article  CAS  Google Scholar 

  3. Dara M, Grzemska M, Kimerling ME, Reyes H, Zagorskiy A. Guidelines for control of tuberculosis in prisons. Tuberculosis Coalition for Technical Assistance and International Committee of the Red Cross; United States; 2009.

  4. Bone A, Aerts A, Grzemska M, Kimerling M, Kluge H, Levy M, et al. Tuberculosis control in prisons: a manual for programme managers. Geneva: World Health Organization; 2000.

    Google Scholar 

  5. Dara M, Acosta CD, Melchers NVSV, Al-Darraji HAA, Chorgoliani D, Reyes H, et al. Tuberculosis control in prisons: current situation and research gaps. Int J Infect Dis. 2015;32:111–7.

    Article  Google Scholar 

  6. Ferreira Júnior S, de Oliveira HB, Marin-Léon L. Conhecimento, atitudes e práticas sobre tuberculose em prisões e no serviço público de saúde. Rev Bras Epidemiol. 2013;16:100–13.

    Article  Google Scholar 

  7. de Souza KMJ, Villa TCS, Assolini FEP, Beraldo AA, França UdM, Protti ST, et al. Atraso no diagnóstico da tuberculose em sistema prisional: a experiência do doente apenado. Texto Contexto Enferm. 2012;21:17–25.

    Article  Google Scholar 

  8. Valença MS, Possuelo LG, Cezar-Vaz MR, da Silva PEA. Tuberculose em presídios brasileiros: uma revisão integrativa da literatura. Ciênc Saúde Coletiva. 2016;21:2147–60.

    Article  Google Scholar 

  9. Gois SM, Santos Junior HPdO, Silveira MdFdA, Gaudêncio MMdP. Para além das grades e punições: uma revisão sistemática sobre a saúde penitenciária. Ciênc Saúde Coletiva. 2012;17:1235–46.

    Article  Google Scholar 

  10. Ferreira AP, Silva PMCA, Godinho MR, Nichele CdST. Análise do sistema prisional brasileiro: revisão sistemática da situação de saúde na população privada de liberdade. Interfaces Científicas Humanas Sociais. 2020;8:365–85.

    Article  Google Scholar 

  11. Beaudry G, Zhong S, Whiting D, Javid B, Frater J, Fazel S. Managing outbreaks of highly contagious diseases in prisons: a systematic review. BMJ Glob Health. 2020;5: e003201.

    Article  Google Scholar 

  12. Edge CL, King EJ, Dolan K, McKee M. Prisoners co-infected with tuberculosis and HIV: a systematic review. J Int AIDS Soc. 2016;19:20960.

    Article  Google Scholar 

  13. Droznin M, Johnson A, Johnson AM. Multidrug resistant tuberculosis in prisons located in former Soviet countries: a systematic review. PLoS ONE. 2017;12: e0174373.

    Article  Google Scholar 

  14. Baussano I, Williams BG, Nunn P, Beggiato M, Fedeli U, Scano F. Tuberculosis incidence in prisons: a systematic review. PLoS Med. 2010;7: e1000381.

    Article  Google Scholar 

  15. Moreira TR, Lemos AC, Colodette RM, Gomes AP, Batista RS. Prevalência de tuberculose na população privada de liberdade: revisão sistemática e metanálise. Rev Panam Salud Publica. 2019;43:1–9.

    Article  Google Scholar 

  16. Melese A, Demelash H. The prevalence of tuberculosis among prisoners in Ethiopia: a systematic review and meta-analysis of published studies. Arch Public Health. 2017;75:37.

    Article  Google Scholar 

  17. da Silva BN, Temoteo RCdA, Véras GCB, Silva CRDV. Fatores predisponentes de tuberculose em indivíduos privados de liberdade: revisão integrativa. Arch Health Sci (Online). 2019;26:67–71.

    Google Scholar 

  18. Van Hout MC, Mhlanga-Gunda R. Contemporary women prisoners health experiences, unique prison health care needs and health care outcomes in sub Saharan Africa: a scoping review of extant literature. BMC Int Health Hum Rights. 2018;18:31.

    Article  Google Scholar 

  19. Kuupiel D, Vezi P, Bawontuo V, Osei E, Mashamba-Thompson TP. Tuberculosis active case-finding interventions and approaches for prisoners in sub-Saharan Africa: a systematic scoping review. BMC Infect Dis. 2020;20:570.

    Article  Google Scholar 

  20. Peters MDJ, Godfrey C, McInerney P, Munn Z, Tricco AC, Khalil H. Chapter 11: Scoping reviews—JBI manual for evidence synthesis—JBI Global Wiki. 2020. https://jbi-global-wiki.refined.site/space/MANUAL/4687342/Chapter+11%3A+Scoping+reviews. Accessed 19 Jul 2022.

  21. Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169:467–73.

    Article  Google Scholar 

  22. Lee SH. Tuberculosis infection and latent tuberculosis. Tuberc Respir Dis (Seoul). 2016;79:201–6.

    Article  Google Scholar 

  23. Joanna Briggs Institute. Critical appraisal tools—critical appraisal tools | JBI. 2020. https://jbi.global/critical-appraisal-tools. Accessed 19 Jul 2022.

  24. Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58.

    Article  Google Scholar 

  25. World Bank. World Bank list of economies (June 2020). 2020.

  26. Schwarzer G. General package for meta-analysis. 4.19–1. 2021.

  27. Callú PC, Lozano JLA, Fiol ARM, Mandujano EP, Montalvo JAH, Gómez MGR. Tuberculosis en un centro de readaptación social del noroeste de México: estudio retrospectivo del periodo 1999–2000, Tijuana, Baja California. Enf Infec Microbiol. 2006;26:94–100.

    Google Scholar 

  28. Kanyerere HS, Banda RP, Gausi F, Salaniponi FM, Harries AD, Mpunga J, et al. Surveillance of tuberculosis in Malawian prisons. Public Health Action. 2012;2:10–4.

    Article  CAS  Google Scholar 

  29. Reis AJ, David SMMd, Nunes LdS, Valim ARdM, Possuelo LG. Recent transmission of drug-resistant Mycobacterium tuberculosis in a prison population in southern Brazil. J Bras Pneumol. 2016;42:286–9.

    Article  Google Scholar 

  30. Anderson KM, Keith EP, Norsted SW. Tuberculosis screening in Washington state male correctional facilities. Chest. 1986;89:817–21.

    Article  CAS  Google Scholar 

  31. Kuhleis D, Ribeiro AW, Costa ERD, Cafrune PI, Schmid KB, da Costa LL, et al. Tuberculosis in a southern Brazilian prison. Mem Inst Oswaldo Cruz. 2012;107:909–15.

    Article  Google Scholar 

  32. Assefzadeh M, Barghi RG, Shahidi SS. Tuberculosis case—finding and treatment in the central prison of Qazvin province, Islamic Republic of Iran. East Mediterr Health J. 2009;15:258–63.

    Article  CAS  Google Scholar 

  33. Prasad BM, Thapa B, Chadha SS, Das A, Babu ER, Mohanty S, et al. Status of tuberculosis services in Indian prisons. Int J Infect Dis. 2017;56:117–21.

    Article  Google Scholar 

  34. Shah SA, Ali M, Ahmad M, Hamadan U. Screening of jail inmates for HIV and tuberculosis. P J M H S. 2013;7:172, 175.

    Google Scholar 

  35. Öngen G, Börekçi Ş, İçmeli ÖS, Birgen N, Karagül G, Akgün S, et al. Pulmonary tuberculosis incidence in Turkish prisons: importance of screening and case finding strategies. Tuberk Toraks. 2013;61:21–7.

    Article  Google Scholar 

  36. Chiang C-Y, Hsu C-J, Hsu P-K, Suo J, Lin T-P. Pulmonary tuberculosis in the Taiwanese prison population. J Formos Med Assoc. 2002;101:537–41.

    Google Scholar 

  37. Shrestha G, Yadav DK, Gautam R, Mulmi R, Baral D, Pokharel PK. Pulmonary tuberculosis among male inmates in the largest prison of eastern Nepal. Tuberc Res Treat. 2019;2019: e3176167.

    Google Scholar 

  38. Salazar-De La Cuba AL, Ardiles-Paredes DF, Araujo-Castillo RV, Maguiña JL. High prevalence of self-reported tuberculosis and associated factors in a nation-wide census among prison inmates in Peru. Trop Med Int Health. 2019;24:328–38.

    Article  Google Scholar 

  39. Mallick G, Shewade HD, Agrawal TK, Kumar AMV, Chadha SS. Enhanced tuberculosis case finding through advocacy and sensitisation meetings in prisons of Central India. Public Health Action. 2017;7:67–70.

    Article  CAS  Google Scholar 

  40. Costa-Junior AO, Silva Júnior JLRd, Costa ACd, Kipnis A, Rabahi MF, Junqueira-Kipnis AP, et al. Tuberculose latente em indivíduos de uma unidade prisional do centro oeste do Brasil. Rev Patol Trop. 2016;45(1):12–22.

    Article  Google Scholar 

  41. Martín V, Brugos M, Valcarcel I. Prevalencia de tratamiento de la infección tuberculosa en la prisión provincial. Rev Esp Salud Publica. 2000;74:00–00.

    Article  Google Scholar 

  42. Hussain H, Akhtar S, Nanan D. Prevalence of and risk factors associated with Mycobacterium tuberculosis infection in prisoners, North West Frontier Province, Pakistan. Int J Epidemiol. 2003;32:794–9.

    Article  Google Scholar 

  43. Santos AdS, de Oliveira RD, Lemos EF, Lima F, Cohen T, Cords O, et al. Yield, efficiency, and costs of mass screening algorithms for tuberculosis in Brazilian prisons. Clin Infect Dis. 2021;72:771–7.

    Article  Google Scholar 

  44. Al-Darraji HAA, Altice FL, Kamarulzaman A. Undiagnosed pulmonary tuberculosis among prisoners in Malaysia: an overlooked risk for tuberculosis in the community. Trop Med Int Health. 2016;21:1049–58.

    Article  Google Scholar 

  45. White MC, Tulsky JP, Portillo CJ, Menendez E, Cruz E, Goldenson J. Tuberculosis prevalence in an urban jail: 1994 and 1998. Int J Tuberc Lung Dis. 2001;5:400–4.

    CAS  Google Scholar 

  46. Sretrirutchai S, Silapapojakul K, Palittapongarnpim P, Phongdara A, Vuddhakul V. Tuberculosis in Thai prisons: magnitude, transmission and drug susceptibility. Int J Tuberc Lung Dis. 2002;6:208–14.

    CAS  Google Scholar 

  47. Nyangulu DS, Harries AD, Kang’ombe C, Yadidi AE, Chokani K, Cullinan T, et al. Tuberculosis in a prison population in Malawi. Lancet. 1997;350:1284–7.

    Article  CAS  Google Scholar 

  48. Habeenzu C, Mitarai S, Lubasi D, Mudenda V, Kantenga T, Mwansa J, et al. Tuberculosis and multidrug resistance in Zambian prisons, 2000–2001. Int J Tuberc Lung Dis. 2007;11:1216–20.

    CAS  Google Scholar 

  49. Aily DCG, Antonio Pistarin Berra J, Pires Brandão A, Chimara E. Tuberculosis, HIV and TB/HIV co-infection in the Prison System of Itirapina, São Paulo, Brazil. R Inst Adolfo Lutz. 2013;49:288–94.

    Google Scholar 

  50. Macedo LR, Maciel ELN, Struchiner CJ, Macedo LR, Maciel ELN, Struchiner CJ. Tuberculose na população privada de liberdade do Brasil, 2007–2013*. Epidemiol Serv Saúde. 2017;26:783–94.

    Article  Google Scholar 

  51. Henostroza G, Topp SM, Hatwiinda S, Maggard KR, Phiri W, Harris JB, et al. The high burden of tuberculosis (TB) and human immunodeficiency virus (HIV) in a Large Zambian Prison: a public health alert. PLoS ONE. 2013;8: e67338.

    Article  CAS  Google Scholar 

  52. Sanchez A, Larouzé B, Espinola AB, Pires J, Capone D, Gerhardt G, et al. Screening for tuberculosis on admission to highly endemic prisons? The case of Rio de Janeiro State prisons. Int J Tuberc Lung Dis. 2009;13:1247–52.

    CAS  Google Scholar 

  53. Noeske J, Kuaban C, Amougou G, Piubello A, Pouillot R. Pulmonary tuberculosis in the Central Prison of Douala, Cameroon. East Afr Med J. 2006;83:25–30.

    Article  CAS  Google Scholar 

  54. Aerts A, Habouzit M, Mschiladze L, Malakmadze N, Sadradze N, Menteshashvili O, et al. Pulmonary tuberculosis in prisons of the ex-USSR state Georgia: results of a nation-wide prevalence survey among sentenced inmates. Int J Tuberc Lung Dis. 2000;4:1104–10.

    CAS  Google Scholar 

  55. Banu S, Hossain A, Uddin MKM, Uddin MR, Ahmed T, Khatun R, et al. Pulmonary tuberculosis and drug resistance in Dhaka Central Jail, the largest prison in Bangladesh. PLoS ONE. 2010;5: e10759.

    Article  Google Scholar 

  56. Alarcón-Robayo JF, Martinez-Casallas L, Samir-Sánchez M, Valderrama-Mendoza JS, Bados-Enriquez DM, Jiménez-Canizales CE. Prevalencia de tuberculosis pulmonar en población privada de la libertad de 10 centros penitenciarios en Colombia. Acta Méd Peru. 2013;2016:202–7.

    Google Scholar 

  57. Lemos ACM, Matos ED, Bittencourt CN. Prevalência de TB ativa e TB latente em internos de um hospital penal na Bahia. J Bras Pneumol. 2009;35:63–8.

    Article  Google Scholar 

  58. Winetsky DE, Almukhamedov O, Pulatov D, Vezhnina N, Dooronbekova A, Zhussupov B. Prevalence, risk factors and social context of active pulmonary tuberculosis among prison inmates in Tajikistan. PLoS ONE. 2014;9: e86046.

    Article  Google Scholar 

  59. Valença MS, Scaini JLR, Abileira FS, Gonçalves CV, von Groll A, Silva PEA. Prevalence of tuberculosis in prisons: risk factors and molecular epidemiology. Int J Tuberc Lung Dis. 2015;19:1182–7.

    Article  Google Scholar 

  60. Berihun YA, Nguse TM, Gebretekle GB. Prevalence of tuberculosis and treatment outcomes of patients with tuberculosis among inmates in Debrebirhan Prison, North Shoa Ethiopia. Ethiop J Health Sci. 2018;28:347–54.

    Article  Google Scholar 

  61. Kalonji GM, De Connick G, Okenge Ngongo L, Kazumba Nsaka D, Kabengele T, Tshimungu Kandolo F, et al. Prevalence of tuberculosis and associated risk factors in the Central Prison of Mbuji-Mayi, Democratic Republic of Congo. Trop Med Health. 2016;44:30.

    Article  Google Scholar 

  62. Addis Z, Adem E, Alemu A, Birhan W, Mathewos B, Tachebele B, et al. Prevalence of smear positive pulmonary tuberculosis in Gondar prisoners, North West Ethiopia. Asian Pac J Trop Med. 2015;8:127–31.

    Article  Google Scholar 

  63. Fuge TG, Ayanto SY. Prevalence of smear positive pulmonary tuberculosis and associated risk factors among prisoners in Hadiya Zone prison, Southern Ethiopia. BMC Res Notes. 2016;9:201.

    Article  Google Scholar 

  64. Moges B, Amare B, Asfaw F, Tesfaye W, Tiruneh M, Belyhun Y, et al. Prevalence of smear positive pulmonary tuberculosis among prisoners in North Gondar Zone Prison, northwest Ethiopia. BMC Infect Dis. 2012;12:352.

    Article  Google Scholar 

  65. Sanchez A, Gerhardt G, Natal S, Capone D, Espinola A, Costa W, et al. Prevalence of pulmonary tuberculosis and comparative evaluation of screening strategies in a Brazilian prison. Int J Tuberc Lung Dis. 2005;9:633–9.

    CAS  Google Scholar 

  66. Séri B, Koffi A, Danel C, Ouassa T, Blehoué M-A, Ouattara E, et al. Prevalence of pulmonary tuberculosis among prison inmates: a cross-sectional survey at the Correctional and Detention Facility of Abidjan. Côte d’Ivoire PLOS ONE. 2017;12: e0181995.

    Article  Google Scholar 

  67. Ali S, Haileamlak A, Wieser A, Pritsch M, Heinrich N, Loscher T, et al. Prevalence of pulmonary tuberculosis among prison inmates in Ethiopia, a cross-sectional study. PLoS ONE. 2015;10: e0144040.

    Article  Google Scholar 

  68. Owokuhaisa J, Thokerunga E, Bazira J. Prevalence of pulmonary tuberculosis among prison inmates at Mbarara Central Prison, South Western Uganda. Adv Res. 2014;2:618–25.

    Article  Google Scholar 

  69. Adesokan HK, Cadmus EO, Adeyemi WB, Lawal O, Ogunlade CO, Osman E, et al. Prevalence of previously undetected tuberculosis and underlying risk factors for transmission in a prison setting in Ibadan, south-western Nigeria. Afr J Med Med Sci. 2014;43(Suppl 1):45–50.

    CAS  Google Scholar 

  70. Vieira AA, Ribeiro SA, de Siqueira AM, Galesi VMN, dos Santos LAR, Golub JE. Prevalence of patients with respiratory symptoms through active case finding and diagnosis of pulmonary tuberculosis among prisoners and related predictors in a jail in the city of Carapicuíba, Brazil. Rev Bras Epidemiol. 2010;13:641–50.

    Article  Google Scholar 

  71. Jordan AM, Podewils LJ, Castro KG, Zishiri V, Charalambous S. Prevalence and risk factors of tuberculosis disease in South African correctional facilities in 2015. Int J Tuberc Lung Dis. 2019;23:1198–204.

    Article  CAS  Google Scholar 

  72. Gizachew Beza M, Hunegnaw E, Tiruneh M. Prevalence and associated factors of tuberculosis in prisons settings of East Gojjam Zone, Northwest Ethiopia. Int J Bacteriol. 2017;2017:3826980.

    Article  Google Scholar 

  73. Hatwiinda S, Topp SM, Siyambango M, Harris JB, Maggard KR, Chileshe C, et al. Poor continuity of care for TB diagnosis and treatment in Zambian prisons: a situation analysis. Trop Med Int Health. 2018;23:243–50.

    Article  CAS  Google Scholar 

  74. Valença MS, Cezar-Vaz MR, Brum CB, da Silva PEA. O processo de detecção e tratamento de casos de tuberculose em um presídio. Ciênc Saúde Coletiva. 2016;21:2111–22.

    Article  Google Scholar 

  75. Paro Pedro HDS, Tonelli Nardi SM, Ferreira Pereira MI, Assad Goloni MDR, Pires FC, Tolentino FM, et al. Detecção do Mycobacterium tuberculosis no sistema penitenciário. Rev Patol Trop. 2012. https://doi.org/10.5216/rpt.v40i4.16759.

    Article  Google Scholar 

  76. Gray BJ, Perrett SE, Gudgeon B, Shankar AG. Investigating the prevalence of latent tuberculosis infection in a UK remand prison. J Public Health. 2020;42:e12–7.

    Google Scholar 

  77. Bhatnagar T, Ralte M, Ralte L, Chawnglungmuana L, Sundaramoorthy L, Chhakchhuak L. Intensified tuberculosis and HIV surveillance in a prison in Northeast India: implementation research. PLoS ONE. 2019;14: e0219988.

    Article  CAS  Google Scholar 

  78. Katyal M, Leibowitz R, Venters H. IGRA-based screening for latent tuberculosis infection in persons newly incarcerated in New York City jails. J Correct Health Care. 2018;24:156–70.

    Article  Google Scholar 

  79. Merid Y, Woldeamanuel Y, Abebe M, Datiko DG, Hailu T, Habtamu G, et al. High utility of active tuberculosis case finding in an Ethiopian prison. Int J Tuberc Lung Dis. 2018;22:524–9.

    Article  CAS  Google Scholar 

  80. Telisinghe L, Fielding KL, Malden JL, Hanifa Y, Churchyard GJ, Grant AD, et al. High tuberculosis prevalence in a South African Prison: the need for routine tuberculosis screening. PLoS ONE. 2014;9: e87262.

    Article  Google Scholar 

  81. Adane K, Spigt M, Ferede S, Asmelash T, Abebe M, Dinant G-J. Half of pulmonary tuberculosis cases were left undiagnosed in prisons of the Tigray Region of Ethiopia: implications for tuberculosis control. PLoS ONE. 2016;11: e0149453.

    Article  Google Scholar 

  82. Banu S, Rahman MdT, Uddin MKM, Khatun R, Khan MdSR, Rahman MdM, et al. Effect of active case finding on prevalence and transmission of pulmonary tuberculosis in Dhaka Central Jail, Bangladesh. PLoS ONE. 2015;10: e0124976.

    Article  Google Scholar 

  83. Carbonara S, Babudieri S, Longo B, Starnini G, Monarca R, Brunetti B, et al. Correlates of Mycobacterium tuberculosis infection in a prison population. Eur Respir J. 2005;25:1070–6.

    Article  CAS  Google Scholar 

  84. Cunha EAT, Marques M, Evangelista MdSN, Pompilio MA, Yassuda RTS, Souza ASd. A diagnosis of pulmonary tuberculosis and drug resistance among inmates in Mato Grosso do Sul, Brazil. Rev Soc Bras Med Trop. 2018;51:324–30.

    Article  Google Scholar 

  85. Sanchez A, Massari V, Gerhardt G, Espinola AB, Siriwardana M, Camacho LAB, et al. X ray screening at entry and systematic screening for the control of tuberculosis in a highly endemic prison. BMC Public Health. 2013;13:983.

    Article  Google Scholar 

  86. Kiter G, Arpaz S, Keskin S, Sezgin N, Budin D, Seref O. Tuberculosis in Nazilli District Prison, Turkey, 1997–2001. Int J Tuberc Lung Dis. 2003;7:153–8.

    CAS  Google Scholar 

  87. Mandizvidza A, Dlodlo RA, Chinnakali P, Mugauri HD, Dube F, Gaka E, et al. Tuberculosis case finding cascade and treatment outcomes among male inmates in two prisons in Zimbabwe. Tuberc Res Treat. 2020;2020: e5829471.

    Google Scholar 

  88. Koo DT, Baron RC, Rutherford GW. Transmission of Mycobacterium tuberculosis in a California State Prison, 1991. Am J Public Health. 1997;87:279–82.

    Article  CAS  Google Scholar 

  89. Nogueira PA, Abrahão RMCdM. Tuberculosis infection and the length of stay of County Jails prisoners in the western sector of the city of São Paulo. Rev Bras Epidemiol. 2009;12:8.

    Google Scholar 

  90. Aguilera XP, González C, Nájera-De Ferrari M, Hirmas M, Delgado I, Olea A, et al. Tuberculosis in prisoners and their contacts in Chile: estimating incidence and latent infection. Int J Tuberc Lung Dis. 2016;20:63–70.

    Article  CAS  Google Scholar 

  91. Adib SM, Al-Takash H, Al-Hajj C. Tuberculosis in Lebanese Jails: prevalence and risk factors. Eur J Epidemiol. 1999;15:253–60.

    Article  CAS  Google Scholar 

  92. Abrahão RMCM, Nogueira PA, Malucelli MIC. Tuberculosis in county jail prisoners in the western sector of the city of São Paulo, brazil. Int J Tuberc Lung Dis. 2006;10:203–8.

    Google Scholar 

  93. Nogueira PA, Abrahão RMCdM, Galesi VMN. Tuberculosis and latent tuberculosis in prison inmates. Rev Saúde Pública. 2012;46:119–27.

    Article  Google Scholar 

  94. Margolis B, Al-Darraji HAA, Wickersham JA, Kamarulzaman A, Altice FL. Prevalence of tuberculosis symptoms and latent tuberculous infection among prisoners in northeastern Malaysia. Int J Tuberc Lung Dis. 2013;17:1538–44.

    Article  CAS  Google Scholar 

  95. Chekesa B, Gumi B, Chanyalew M, Zewude A, Ameni G. Prevalence of latent tuberculosis infection and associated risk factors in prison in East Wollega Zone of western Ethiopia. PLoS ONE. 2020;15: e0233314.

    Article  CAS  Google Scholar 

  96. Navarro PDd, Almeida INd, Kritski AL, Ceccato MdG, Maciel MMD, Carvalho WdS, et al. Prevalence of latent Mycobacterium tuberculosis infection in prisoners. J bras pneumol. 2016;42:348–55.

    Article  Google Scholar 

  97. López de Goicoechea-Saiz ME, Sternberg F, Portilla-Sogorb J. Prevalence and associated risk factors of latent tuberculosis infection in a Spanish prison. Rev Esp Sanid Penit. 2018;20:4–10.

    Google Scholar 

  98. Rueda ZV, Arroyave L, Marin D, López L, Keynan Y, Giraldo MR, et al. High prevalence and risk factors associated with latent tuberculous infection in two Colombian prisons. Int J Tuberc Lung Dis. 2014;18:1166–71.

    Article  CAS  Google Scholar 

  99. García-Guerrero J, Marco Mouriño A, Sáiz de la Hoya Zamácola P, Vera-Remartínez EJ, Grupo de estudio PREVALHEP de prisiones. Multi-centre study of the prevalence of latent tuberculosis infection amongst inmates in Spanish prisons. Rev Esp Sanid Penit. 2010;12:79–85.

    Google Scholar 

  100. Ritter C, Elger BS. Prevalence of positive tuberculosis skin tests during 5 years of screening in a Swiss remand prison. Int J Tuberc Lung Dis. 2012;16:65–9.

    Article  CAS  Google Scholar 

  101. Mabud TS, de LourdesDelgado Alves M, Ko AI, Basu S, Walter KS, Cohen T, et al. Evaluating strategies for control of tuberculosis in prisons and prevention of spillover into communities: an observational and modeling study from Brazil. PLoS Med. 2019;16: e1002737.

    Article  Google Scholar 

  102. Abou Jaoude GJ, Garcia Baena I, Nguhiu P, Siroka A, Palmer T, Goscé L, et al. National tuberculosis spending efficiency and its associated factors in 121 low-income and middle-income countries, 2010–19: a data envelopment and stochastic frontier analysis. Lancet Glob Health. 2022;10:e649–60.

    Article  Google Scholar 

  103. Tavares AMR. Perfil epidemiológico da tuberculose no setor prisional no Brasil. J Health Sci Inst. 2019;37:367–71.

    Google Scholar 

  104. Pereira JdC, Silva MR, Costa RRd, Guimarães MDC, Leite ICG. Perfil e seguimento dos pacientes com tuberculose em município prioritário no Brasil. Rev Saúde Pública. 2015;49:6.

    Google Scholar 

  105. Saita NM, Andrade RLdP, Bossonario PA, Faria MGBFd, Catoia EA, Ferreira MRL, et al. Tuberculose nos presídios e fatores associados ao local de notificação no estado de São Paulo: um estudo caso-controle. RSD. 2021;10: e121101119319.

    Article  Google Scholar 

  106. Fórum Brasileiro de Segurança Pública. Anuário Brasileiro de Segurança Pública 2020. Fórum Brasileiro de Segurança Pública: Fundação Ford; Open Society Foundations—OSF; Federação Nacional das Empresas de Segurança e Transporte de Valores—FENAVIST; 2020.

  107. Melo RLB, dos Santos AAP, Tavares CM, dos Santos EO, Santos VB, dos Santos WB. Análise epidemiológica dos casos novos de tuberculose em uma população privada de liberdade no Nordeste brasileiro. RSD. 2022;11: e22411124903.

    Article  Google Scholar 

  108. Global tuberculosis report 2022. Geneva: World Health Organization; 2022. Licence: CC BY-NC-SA 3.0 IGO.

Download references

Acknowledgements

Not applicable.

Funding

Not applicable.

Author information

Authors and Affiliations

  1. Instituto de Higiene e Medicina Tropical (IHMT), Universidade Nova de Lisboa, Rua da Junqueira 100, 1349-008, Lisbon, Portugal

    Aline Ferreira Placeres & Débora de Almeida Soares

  2. Programa de Pós Graduação em Enfermagem, Universidade Federal de Pelotas, Pelotas, Brazil

    Felipe Mendes Delpino

  3. Escola de Enfermagem de Ribeirão Preto (EERP/USP), Universidade de São Paulo, São Paulo, Brazil

    Heriederson Sávio Dias Moura, Márcio Souza dos Santos & Ricardo Alexandre Arcêncio

  4. Universidade Estadual do Norte do Paraná, Campus Luiz Meneguel de Bandeirantes, Bandeirantes, Brazil

    Alessandro Rolim Scholze

  5. Global Health and Tropical Medicine, Instituto de Higiene e Medicina Tropical, Universidade NOVA de Lisboa, Lisbon, Portugal

    Inês Fronteira

Authors
  1. Aline Ferreira Placeres
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Débora de Almeida Soares
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Felipe Mendes Delpino
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Heriederson Sávio Dias Moura
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Alessandro Rolim Scholze
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Márcio Souza dos Santos
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ricardo Alexandre Arcêncio
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Inês Fronteira
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

AP conceived the study together with IF provided input over the study process. DS, and AP extracted the data, assisting in manuscript drafting under IF guidance. FD performed the analyses. DS, AS, MS and HM evaluated the quality of studies. IF and RA provided expert input over the review process and final drafting. All authors read and approved the fnal manuscript.

Corresponding author

Correspondence to Aline Ferreira Placeres.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1.

Search strategy.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Placeres, A.F., de Almeida Soares, D., Delpino, F.M. et al. Epidemiology of TB in prisoners: a metanalysis of the prevalence of active and latent TB. BMC Infect Dis 23, 20 (2023). https://doi.org/10.1186/s12879-022-07961-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12879-022-07961-8

Keywords

  • Meta-analysis
  • Prevalence
  • Tuberculosis
  • Prisoners
  • Prisons
  • Population deprived of liberty

BMC Infectious Diseases

ISSN: 1471-2334

Contact us